Updated results of surufatinib combined with gemcitabine and cisplatin and immune checkpoint inhibitor (ICI) for unresectable locally advanced or metastatic intrahepatic cholangiocarcinoma.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Zhong Jingtao, Jiang Yubo, Geng Xiaodan, Shi Xuetao
Institutions: Shandong Tumor Hospital, Shandong First Medical University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162524977
Cites:
Cited by:
Related to: